Ferozsons Laboratories Ltd 2024 AR2
The report highlights Ferozsons Laboratories Limited's performance and initiatives for the fiscal year 2023-2024. The company expanded its healthcare portfolio with key launches like Ferulin, Pakistan's first locally manufactured human insulin, and Sematide, a locally produced GLP-1 agonist, to address the rising prevalence of diabetes. Ferozsons also entered into a voluntary licensing agreement with Gilead Sciences to manufacture and distribute generic lenacapavir for HIV treatment and prevention. On the environmental front, the company invested in renewable energy by operating a one-megawatt solar power plant and initiating the installation of a second one-megawatt plant. Additionally, Ferozsons demonstrated its commitment to social responsibility through community care initiatives, including the Ferozsons Initiative for Research Excellence (FIRE) and the Will-Med forum to empower women in medicine.
Company: Ferozsons Laboratories Ltd
Sector: Health Care
Country: Pakistan
Year: 2024
Type: AR2
Pages: 218
Ferozsons Laboratories Ltd
Annual Report
The report highlights Ferozsons Laboratories Limited's performance and initiatives for the fiscal year 2023-2024. The company expanded its healthcare portfolio with key launches like Ferulin, Pakistan's first locally manufactured human insulin, and Sematide, a locally produced GLP-1 agonist, to address the rising prevalence of diabetes. Ferozsons also entered into a voluntary licensing agreement with Gilead Sciences to manufacture and distribute generic lenacapavir for HIV treatment and prevention. On the environmental front, the company invested in renewable energy by operating a one-megawatt solar power plant and initiating the installation of a second one-megawatt plant. Additionally, Ferozsons demonstrated its commitment to social responsibility through community care initiatives, including the Ferozsons Initiative for Research Excellence (FIRE) and the Will-Med forum to empower women in medicine.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jul 1, 2023 - Jun 30, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees